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Objective: To describe the epidemiology of excessive mumps cases during the year 2000, within the metropolitan 
area of Walsall, UK; to assess the impact of the mumps outbreak on morbidity; and to inform future communicable 
disease control strategy. 
Methods: Demographic records, school attendance, uptake of the measles-mumps-rubella (MMR) vaccine, and 
mumps-associated admission to hospital, were reviewed for all Walsall residents diagnosed and notified with mumps 
during the year 2000. 
Results: There were 200 mumps notifications in 2000 (76.6 per 100 000) representing the highest incidence in 
England. Only 91 of the notified cases were salivary antibody positive for mumps IgM, and 32 were negative, although 
77 were not tested. Since 1990, annual totals have never previously exceeded 20. Over 90% of patients were ~20 
years old, with a peak age group of 10-14 years; 88% attended schools located within Walsall. The pattern of spread 
suggested that the outbreak proceeded through schools from north to south in the more deprived western half of 
the metropolitan area. Most cases (136, 68%) had received one (99, 49.5%) or two (37, 18.5%) doses of MMR 
vaccine; cases 220 years old had never received MMR. Six cases (aged 4-14 years) were admitted to hospital, all 
with a successful outcome, including one male with meningitis and one female with pancreatitis. Current uptake of 
the MMR vaccine at 24 months has dropped to below 90% in recent years, as in most parts of the UK. 
Conclusions: Future mumps outbreaks in schools, and among older age groups, can be predicted, since most older 
children and young adults have received only one dose of MMR vaccine or no vaccination at all. Primary vaccine 
failure is well described in mumps, and cases during outbreaks can include recipients of two MMR vaccine doses. It 
was fortunate that no severe morbidity was associated with this outbreak (prior to MMR, two to four mumps deaths 
occurred annually in England and Wales). Measures to restore the uptake of MMR to the previous levels of above 
90-95% will be necessary to reduce the risk of the mumps virus circulating within communities. Older children are 
susceptible, and it may be advisable to ensure second-dose MMR uptake while they are still at or when they leave 
school, or when they enter college, university or the military. 
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Mumps is caused by a paramyxovirus, antigenically 
related to parainfluenza virus, that predominantly affects 
children and typically presents as a pyrexial illness with 
sore throat, malaise, and painful chewing or swallowing 
associated with unilateral or bilateral parotitis. Fatality 
is rare, but infrequent clinical complications include: 
aseptic meningoencephalitis, rarely producing permanent 
nerve deafness; orchitis and oophoritis, rarely associated 
with sterility: and acute abdomen presentation, usually 
associated with pancreatitis.’ Airborne droplet spread 
has been responsible for outbreaks, recently described 
from Kansas (1991)2 and Tennessee (1994)3 in the USA, 
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Switzerland (1995, 1996),4,5 Japan (1996),6 Canada (1999): 
and Spain (2OOl).s 
In England and Wales, mumps almost disappeared 
in the mid-1990s but confirmed cases have risen in 
recent years (1998,67 cases; 1999,262 cases; 2000,482 
cases). During 2000, outbreaks were noted in Walsall, 
West Midlands, and in Blackburn, in the northwest 
of England. In 2001, outbreaks were noted in other 
parts of England, especially the northwest. Most mumps 
cases have occurred in children just too old to have 
been given the measles-mumps-rubella (MMR) vac- 
cine, introduced in 1988, or in those given only one dose 
of MMR and not the two required to provide better 
protection. As a result, mumps cases have typically 
occurred in teenagers. 
The present report is a review of the circumstances 
associated with the year 2000 outbreak of mumps in the 
metropolitan borough of Walsall, which reported the 
highest incidence of mumps in England at 76.6 cases per 
100 000 population. 
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METHODS 
Mumps is a notifiable disease, and details of all clinically 
ascertained cases in Walsall are forwarded to the Public 
Health Directorate. Data include demographic details, 
date of symptom onset, and MMR vaccine adminis- 
tration. The attending physician may also test saliva for 
mumps antibody, and the results of this are also made 
available. During 2000, all mumps data were checked, 
particularly for MMR vaccine details and missing 
information. It is recognized that earlier general 
practitioner (GP)-recorded data for vaccine uptake may 
be unreliable, particularly for children born during 
1978-89, and that earlier recipients of MR (measles- 
rubella) vaccine did not count as receiving the mumps 
component. Referring physicians were also questioned 
about mumps-related hospital admissions, as were major 
receiving hospitals used by Walsall residents. The 
education authority provided details of school 
attendance in every child case. 
Mumps notification data were obtained from the 
neighboring West Midlands metropolitan borough 
areas of Wolverhampton, Sandwell, and Dudley, which 
comprise with Walsall the industrial urban area of the 
Black Country (about one million population). The area 
borders the northwest of Birmingham, the UK’s second 
city. Approximately a quarter of a million people live 
in Walsall, famous for its leather industry and its soccer 
team, nicknamed the Saddlers. The western half of the 
borough contains the most deprived and densely popu- 
lated areas of Walsall. 
RESULTS 
There were precisely 200 mumps cases notified in Walsall 
during 2000, representing 76.6 cases per 100 000 popu- 
lation. This compares with incidence rates (per 100 000) 
of 4.1 in Wolverhampton, 3.2 in Dudley, 1.0 in Sandwell, 
and 12.3 in Birmingham.Table 1 shows available Walsall 
mumps notifications from 1989 to 2000, with low 
levels from 1990 to 1999. There were no clear seasonal 
trends, except for fewer cases during July-August and 
December-January, coinciding with school holidays. 
Excessive numbers in 2000 reverted to normality in 
2001, with six cases during the period January to June 
inclusive. Annual percentage uptakes of the MMR 
vaccine at 24 months in Walsall were: 90.0%, 1996; 
90.3%, 1997;89.5%, 1998;89.1%,1999;and87.1%,2000. 
The last figure compares with: Wolverhampton, 88.6%; 
Dudley, 91.2%; Sandwell, 89.1%; and Birmingham, 
88.6%. 
Of the 200 mumps cases (119 male, 59.5%; 81 
female, 40.5%), 92% were ~20 years of age, with a peak 
age group of lo-14 years (Table 2). Cases 220 years 
of age had never received MMR vaccine. Most cases 
(136, 68%) had received one (99, 49.5%) or two (37, 
18.5%) vaccine doses. However, there is doubt about the 
reliability of GP-recorded vaccine histories for those 
children born before 1990, since many will have received 
one MMR vaccination and one MR vaccination, i.e. one 
dose of mumps vaccine. Thus, in Table 2, the eleven 
lo-14-year-olds and particularly the four 15-19-year- 
olds recorded as having received two doses may be 
overestimates. Salivary testing for mumps antibodies 
was requested in 123 cases, of whom 91 (74%) were 
positive and 32 (260/ ) o were negative (Table 3). Positive 
cases included recipients of two MMR doses. Immune 
status may have influenced requests for salivary testing, 
which was more frequent among recipients of one 
(70/99,70.7%) or two (27/37,73.0%) vaccine doses com- 
pared to non-immunized cases (26/38,40.6%). Negative 
testing tended to associate with higher immune status: 
two doses, 33.3% (9/27); one dose, 25.7% (18/70); no 
vaccine, 19.2% (5/26). 
The distribution of cases according to postcode area 
of residence showed a preponderance in the western 
half of the borough (Figure 1). Four postcode areas in 
the western half each contained >15 cases (Table 4; 
Figure 1). Areas WSl, WVll, WV12, WV13 and WV14 
are shared with neighboring Wolverhampton, with many 
urban communities being distributed across the borough 
Table 1. Yearly notification of mumps cases in Waisall 
Year No. of cases Year No. of cases 
1989 87 1995 8 
1990 23 1996 19 
1991 18 1997 14 
1992 7 1998 3 
1993 8 1999 10 
1994 14 2000 200 
Table 2. Age distribution of the 200 mumps cases and their 
prior immunization status according to number of vaccine doses 
No. of mumps vaccine doses 
Age (years) None One Two Total P/o) 
1 3 3 (1.5) 
2-5 3 5 2 10 (5.0) 
6-9 3 19 20 42 (21.0) 
10-14 20 53 11 84 (42.0) 
15-19 22 19 4 45 (22.5) 
20-29 10 10 (5.0) 
230 6 6 (3.0) 
All ages 64 99 37 200 (100) 
Table 3. Saliva testing for mumps among the 200 cases and 
their prior immunization status according to number of vaccine 
doses 
Cases tested 
Doses of Cases 
vaccine Positive Negative not tested All cases 
None 21 5 38 64 
One 52 18 29 99 
TWO 18 9 10 37 
Total 91 32 77 200 
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Figure 1. Map of Walsall, showing distribution of mumps cases in the year 2000, and location of the four schools pri ncipally 
inthe outbreak. 
boundary. However, Wolverhampton recorded only nine 
mumps cases during 2000, of whom four lived in shared 
postcode areas: WVll, two cases; WVl2, one case; and 
WV14, one case. School attendance provided a more 
likely explanation for mumps transmission during the 
Walsall outbreak. Of the total 200 cases, 176 (88%) 
attended school, all in Walsall. Four postcode areas 
contained more than 10 cases, with dates of onset not 
earlier than February 2000. Table 4 and Figure 1 suggest 
that the outbreak started at Sneyd in the northern part 
of the borough and spread southwards through FF 
Harrison, Willenhall and other schools, ending at Dorothy 
Purcell (the single Wolverhampton case residing in 
WV14 attended this school). Given the dates of onset 
and mumps incubation time, Table 4 suggests a break 
ham 
led 
in transmission during the July-August holidays before 
the outbreak finally reached and ended at Dorothy 
Purcell. Sneyd and Dorothy Purcell are among the largest 
Walsall schools (> 1000 pupils) and could be expected to 
contain a proportionately greater number of cases. 
Six cases (three male; three female), aged 4-14 
years, were admitted to hospital; four had pyrexia and 
severity of ‘flu-like symptoms, and two had recognized 
mumps complications. A lo-year-old male presented to 
primary care with mumps, and again 5 days later with 
fever, headache, and neck stiffness. Aseptic meningitis 
was confirmed after hospital admission, and the patient 
made an uneventful recovery. A 13-year-old female 
presented with mumps, and again 4 days later with a 2- 
day history of abdominal pain and vomiting. Hospital 
Table 4. Distribution by month (according to onset of symptoms) of the year 2000 mumps cases by (a) four postcode areas, each 
containing >I5 cases, and (b) by four schools, each containing 210 cases 
Dee 99 
Postcode 
ws2 
ws3 
WSlO 
WV12 
Other 1 
All areas 
School 
Sneyd 
F F Harrison 
Willenhall 
Dorothy 
Purcell 
Other 1 
All school 
attenders 
Jan 
1 
3 
4 
Feb 
1 
4 
1 
1 
4 
2 
Mar 
2 
20 
11 
2 
22 
1 
9 
Apr May Jlifl JUI Aug Sep Ott Nov Total 
7 4 6 14 5 1 3 1 45 
11 11 5 3 3 2 1 60 
2 3 2 7 17 31 
6 6 2 26 
1 3 3 2 3 5 5 9 38 
200 
12 15 2 2 1 58 
2 1 2 7 1 14 
3 1 5 1 1 11 
10 17 27 
5 4 8 9 9 4 1 10 66 
176 
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admission was followed by persistence of pain and 
pyrexia 24 h later, when persistent abdominal signs 
indicated exploratory laparotomy. No abnormalities were 
detected, and appendicectomy was performed as routine. 
Raised serum amylase levels supported the diagnosis of 
pancreatitis; the patient was treated for this and 
discharged 1 week later. 
DISCUSSION 
Prior to the introduction of the MMR vaccine in 1988, 
epidemics of mumps occurred at 3-yearly intervals in 
England, and the infection was the commonest cause of 
viral meningitis in children. The vaccine accounted for a 
79% reduction in notified cases over 2 years, and an 
interruption of the epidemic cycle.9 This reduction is 
reflected in the Walsall notifications from 1989 to 1991. 
However, surveillance during the 1990s showed an in- 
crease in the proportion of school-age children with no 
mumps antibody, which was consistent with a reduction 
in virus transmission, but which predicted that school 
outbreaks may become more common.1° This led to the 
introduction of a second dose of vaccine in 1996 before 
school entry. The next scenario is that outbreaks are 
possible in universities and military establishments in 
the long term, particularly with the recent reduced 
uptake of MMR which increases the risk of mumps 
circulating within communities. The outbreaks referred 
to earlier occurred in school children, with the exception 
of the Canadian cases, which were associated with social 
gatherings of young adults at ‘rave’ parties.7 The health 
authorities there suggested that the susceptibility to 
mumps among 17-40-year-olds warranted one dose of 
MMR. The spread of mumps within Walsall certainly 
occurred as a progression through its schools in a 
southerly direction, since communities shared with 
neighboring Wolverhampton were largely spared. The 
adult cases were too few in number to indicate any 
spread through other social gatherings. There is un- 
certainty whether airborne droplet spread or direct 
hand-to-hand transmission is responsible for outbreaks. 
The outbreak included 37 cases who had received 
two doses of MMR (including 18 of 27 who were sero- 
logically positive on salivary testing), apart from the 
majority who had received one (99) or no (64) dose. 
Primary vaccine failure is well described in mumps, with 
little evidence for waning immunity (secondary vaccine 
failure).11*12 The outbreaks elsewhere involved cases who 
had previously received mumps or MMR vaccine,2-s 
with specific reference to cases who had received two 
MMR doses.2 Mumps is further complicated by circu- 
lating strain differences that can account for previously 
observed vaccine failures,13,14 and by differences in 
efficacy between strains of mumps vaccines used (the 
Rubini strain of vaccine, which has never been used in 
the UK, has inferior efficacy compared to the Urabe or 
Jeryl Lynn strains). 15,16 In the UK, the Urabe mumps 
vaccine first used in the MMR was associated with 
the rare complication of meningoencephalitis and was 
replaced by the Jeryl Lynn vaccine from 1992. It is 
difficult to understand why this large outbreak first 
occurred in Walsall, but similar outbreaks now occurring 
in other parts of the country suggest a more widespread 
phenomenon. Teenage outbreaks had been predicted, as 
MR (not containing mumps vaccine) rather than MMR 
had to be used in a 1994 school campaign, due to the 
unavailability of eight million doses of MMR.17 While 
recent MMR uptake is marginally lower than that in 
neighboring areas, this would still not explain the 
predominance in the teenage group in Walsall. It may be 
premature of some countries to believe that mumps can 
yet be adequately controlled or eliminated, although 
those same countries have used a two-dose MMR 
schedule for many years. u-20 A note of caution is neces- 
sary when considering outbreaks, since most of the 
factors associated with vaccine failure are not uniformly 
or randomly distributed in a population. Outbreaks 
represent exceptions to usual experience, and modeling 
shows that they tend to lead to underestimation of true 
vaccine efficacy in the population2’ 
It is possible that the total number of notified 
mumps cases was an overestimate, given the number of 
negative salivary tests. Actual total numbers may have 
been underestimated, since not all cases are necessarily 
notified, and since subclinical and mild cases will attract 
medical attention. While genotyping can differentiate 
between mumps vaccine and wild strains, saliva speci- 
mens used for specific IgM detection can be misleading 
in individual cases, which can include those with obvious 
parotitis. The test is not 100% sensitive, and samples 
need to be collected at the appropriate time of 2-6 
weeks after onset. Conversely, IgM reactivity can signify 
cross-reaction with parainfluenza virus antibody. Saliva 
testing is still an invaluable method for surveillance of 
mumps-like illness in the community, particularly during 
periods of low incidence, and will be necessary to support 
case definitions should it be possible to achieve elimi- 
nation.20 
In the meantime, every effort should be made to 
improve uptake of the MMR vaccine. The six admitted 
cases constitute a reminder of the morbidity associated 
with mumps. It is fortunate that the mumps meningitis 
case recovered with no neurologic sequelae, but the 
other case with an acute abdomen arguably endured an 
unnecessary laparotomy. No ascertained cases of mumps 
orchitis were reported, despite the clear increase in 
incidence of this disease reported elsewhere.22 Future 
cases of orchitis and of later associated sterility may well 
emerge with the shift towards an increasing incidence in 
young adults. 
Despite continuing evidence against a causal associ- 
ation between MMR and autism,23 misplaced media 
alarm over the safety of MMR has resulted in declining 
uptake of the vaccine, which the UK government is 
striving hard to counteract. The threat of measles out- 
breaks and associated morbidity is frequently cited to 
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encourage parents to immunize their children. Mumps 
should not be forgotten in this context, and neither 
should the tragedy associated with congenital rubella. 
Even if MMR uptake reverts to higher protective 
coverage (90-95%) at 24 months, it is imperative to 
emphasize the need for the second dose of vaccine. To 
avert future mumps outbreaks in schools, and among 
older age groups, it may be necessary over the next 10 
years to ensure second-dose uptake on leaving school 
and/or on entering college/university or the military. 
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